- And that’s a wrap 2023! Christmas with IR Department
- This is what the ASX and investors expect for gender diversity on your board
- 5 key lessons any company can take away from our foundational ESG report
- What small caps can take away from Amazon’s move to write emissions data into its supplier standards
- How Australian small caps are likely to be impacted by the new ISSB sustainability disclosure standards
Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses
UniSeed: UniSuper makes first venture capital foray with $75m funding (afr.com)
Servatus launches new trial into the effects of live biotherapeutics on insomnia
Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer
Kazia (ASX: KZA) CEO Dr James Garner discusses the enrolment of the first patient into their phase II study of paxalisib in combination with a ketogenic diet to treat glioblastoma (brain cancer)
Join us on Thurs 31 March for "IRD Invest - Project 2025"
As we look to accelerate the integration of advanced technology over the next three years, our fourth IRD Invest conference considers some of the benefits this change will bring, for businesses and society.
We are delighted to showcase a select number of emerging ASX listed tech companies on 31 March. The free virtual event will focus on companies that are paving the way forward with major advances in technology and innovation.
XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference
Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference
Proactive does a deep dive into AdAlta via "Combatting fibrosis"
IR Department celebrates International Women's Day 2022
Learn more about HaemaLogix’s ground-breaking KappaMab technology